Patent Grant
10808047
The invention relates to silver and copper itaconates and poly itaconates, as well as methods of making and using the same, for example, as antimicrobial agents and anti scaling agents.
Microbial contamination, for example of water, human foodstuffs, and animal feeds as well as medical and industrial equipment, packages, containers, and other objects is a worldwide issue. Intensive research has been ongoing in the area for decades, many antimicrobial agents are known and in use, and new antimicrobial products and methods are constantly being developed.
Metals are one class of antimicrobial agents. For example, copper salts such as copper sulfate and copper chloride are used as disinfectants that are odorless and non-irritating, but provide only briefly-sustained disinfection and are known carcinogens and mutagens. Aqueous copper and silver ions are also disinfectants and used, for example, in water systems. However, aqueous copper and silver ions have only a limited stable ionic life and must be regularly replaced.
There remains a need for improved antimicrobial agents.
The invention is based, at least in part, on the discovery that certain silver and/or copper itaconates and poly itaconates have antimicrobial properties. The silver and/or copper itaconates and poly itaconates can be advantageously used as antimicrobial agents, for example as coatings on medical items (e.g., bandages, hospital equipment), consumer goods (e.g., clothing, appliances), and industrial equipment (e.g., food service, water treatment), as well as in additives in paints and other surface treatment formulations. The silver and/or copper itaconates and poly itaconates can also be used as disinfectants (e.g., as a wash, spray, or aerosol). The invention can be used for sanitizing, e.g., food processing and pharmaceutical equipment. Additional applications include mitigation of biofilms in cooling systems or recirculating water systems. The polymer can be compounded with other polymers antimicrobial properties of final formulations.
In various aspects and embodiments, the itaconates (the silver and/or copper itaconates and poly itaconates) have greater stability (e.g., useful half-life) and safety (e.g., do not harm humans, pets, livestock) compared to many known antimicrobial agents. Furthermore, the itaconates are more cost effective than many known antimicrobial agents. Formulation of the invention (e.g., polymeric formulations) can provide extended stability and have strong adhesion to surfaces, resulting in coated surfaces remaining disinfected for extended periods of time. Also on drying the formulation (e.g., as a polymeric layer) can be a thin continuous coated film offering better disinfection compared to prior art salts which tend to flake out. Methods of the invention can be based upon single pot synthesis, thus reducing equipment requirements for manufacturing. Also, unlike many prior art formulations, no hazardous and corrosive inorganic acids are necessarily involved in current formulation, mitigating costs associated to storage handling and safety during production.
Accordingly, in various aspects, the invention provides an itaconate having the formula (I):
wherein R1 and R2 are each independently selected from H, Ag, or Cu; wherein ratio of Ag and/or Cu to itaconate is at least about 1:1; and wherein n is from 1 to 14.
In various aspects, the invention provides a composition comprising a plurality of itaconate molecules (e.g., formula I, or as otherwise disclosed herein), wherein the plurality of itaconate molecules have an average molecular weight of about 500 to 3,500.
In various aspects, the invention provides a solution comprising a plurality of itaconate molecules formula I, or as otherwise disclosed herein).
In various aspects, the invention includes a method of providing an antimicrobial surface comprising coating an article with an itaconate (e.g., formula I, or as otherwise disclosed herein).
In various aspects, the invention provides an article having an antimicrobial coating comprising an itaconate (e.g., formula I, or as otherwise disclosed herein).
In various aspects, the invention provides an antimicrobial coating comprising a silver and/or copper itaconate homopolymer or heteropolymer (e.g., formula I, or as otherwise disclosed herein).
In various aspects, the invention also provides a method for making an itaconate (e.g., formula I, or as otherwise disclosed herein), comprising: (1) electrolyzing of silver (Ag) or copper (Cu) in an itaconic acid (C5H6O4) solution, thereby producing silver or copper itaconate (C5H5AgO4 or C5H5CuO4) and/or disilver or dicopper itaconate (C5H4Ag2O4 or C5H5Cu2O4); and (2) polymerizing the itaconate produced in (1).
In various embodiments, any of the aspects described herein can be combined with one or more of the features discussed below.
In various embodiments, the plurality of poly itaconate molecules have an average molecular weight of about 500, 1000, 1500, 2000, 2500, 3000, or 3,500 (e.g., as measured by MALDI-TOF MS).
In various embodiments, the ratio of Ag and/or Cu to itaconate can be about 0.1 to 2. In particular embodiments, the ratio of Ag and/or Cu to itaconate can be about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2.0 (e.g., with fractions representing average Ag and/or Cu per monomer over the polymer or sample).
In various embodiments, the composition can also comprise about 30 to 5000 ppm of Ag and/or Cu. In particular embodiments, the composition can also comprise about 30, 40, 50, 60, 70, 80, 90, 100, 200, 250, 300, 400, 500, 600, 700, 750, 800, 900, 1000, 1250, 1500, 1750, 2000, 2250, 2500, 2750, 3000, 3500, 4000, 4500, or 5000 ppm of Ag and/or Cu (e.g., as measured by atomic absorption spectroscopy).
In various embodiments, R1 and R2 are each independently selected from H or Ag (e.g., the itaconate is a silver itaconate). Alternatively, the itaconate can be a copper itaconate or a mixed silver-copper itaconate.
In various embodiments, a plurality of itaconate molecules (e.g., an itaconate as described and claimed herein) are comprised in a solution. In various embodiments, the solution is an aqueous solution. In various embodiments, the solution further comprises an alcohol cosolvent. In various embodiments, the solution does not comprise another polymer. In various embodiments, the solution does not comprise another metal and/or antimicrobial agent in addition to the itaconate.
In various embodiments, the solution further comprises free Ag and/or Cu ions complexed with itaconic acid moieties.
In various embodiments, the antimicrobial coating is in an aqueous solution.
In various embodiments, the itaconates can be formulated with an alcohol (e.g., isopropyl alcohol, ethanol) and can be added to hand sanitizer formulation to further enhance broad spectrum efficacy.
In various embodiments, the antimicrobial coating is coating the surface of an article.
In various embodiments, the itaconates can be used as anti scaling agents.
In various embodiments, the method of making the itaconate is conducted as a one pot synthesis.
In various embodiments, the method of making the itaconate is conducted as an aqueous polymerization or an emulsion polymerization.
Various aspects, embodiments, and features of the invention are presented and described in further detail below. However, the foregoing and following descriptions are illustrative and explanatory only and are not restrictive of the invention, as claimed.
The invention is based, at least in part, on the discovery that certain silver and/or copper itaconates and poly itaconates have antimicrobial properties. The silver and/or copper itaconates and poly itaconates can be advantageously used as antimicrobial agents, for example as coatings on medical items (e.g., bandages, hospital equipment), consumer goods (e.g., clothing, appliances), and industrial equipment (e.g., food service, water treatment), as well as in additives in paints and other surface treatment formulations. The silver and/or copper itaconate and poly itaconates can also be used as disinfectants (e.g., as a wash, spray, or aerosol). The invention can be used for sanitizing, e.g., food processing and pharmaceutical equipment. Additional applications include mitigation of biofilms in cooling systems or recirculating water systems. The polymer can be compounded with other polymers to enhance antimicrobial properties of final formulations.
In various aspects and embodiments, the itaconates (the silver and/or copper itaconates and poly itaconates) have greater stability (e.g., useful half-life) and safety (e.g., do not harm humans, pets, livestock) compared to many known antimicrobial agents. Furthermore, the itaconates are more cost effective than many known antimicrobial agents. Formulation of the invention (e.g., polymeric formulations) can provide extended stability and have strong adhesion to surfaces, resulting in coated surfaces remaining disinfected for extended periods of time. Also on drying the formulation (e.g., as a polymeric layer) can be a thin continuous coated film offering better disinfection compared to prior art salts which tend to flake out. Methods of the invention can be based upon single pot synthesis, thus reducing equipment requirements for manufacturing. Also, unlike many prior art formulations, no hazardous and corrosive inorganic acids are necessarily involved in current formulation, mitigating costs associated to storage handling and safety during production.
Itaconates and Poly Itaconates, Compositions Comprising the Same
Accordingly, in various aspects, the invention provides an itaconate having the formula (I):
wherein R1 and R2 are each independently selected from H, Ag, or Cu; wherein ratio of Ag and/or Cu to itaconate is at least about 1:1; and wherein n is from 1 to 14.
In various aspects, the invention provides a composition comprising a plurality of poly itaconate molecules, wherein the plurality of poly itaconate molecules have an average molecular weight of about 500 to 3,500. In various embodiments, the plurality of poly itaconate molecules have an average molecular weight of about 500, 1000, 1500, 2000, 2500, 3000, or 3,500 (e.g., as measured by MALDI-TOF MS).
In various embodiments, the ratio of Ag and/or Cu to itaconate can be about 0.1 to 2. In particular embodiments, the ratio of Ag and/or Cu to itaconate can be about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2.0 (e.g., with fractions representing average Ag and/or Cu per monomer over the polymer or sample).
In various embodiments, the composition can also comprise about 30 to 5000 ppm of Ag and/or Cu. In particular embodiments, the composition can also comprise about 30, 40, 50, 60, 70, 80, 90, 100, 200, 250, 300, 400, 500, 600, 700, 750, 800, 900, 1000, 1250, 1500, 1750, 2000, 2250, 2500, 2750, 3000, 3500, 4000, 4500, or 5000 ppm of Ag and/or Cu (e.g., as measured by atomic absorption spectroscopy).
In various embodiments, R1 and R2 are each independently selected from H or Ag (e.g., the itaconate is a silver itaconate). Alternatively, the itaconate can be a copper itaconate or a mixed silver-copper poly itaconate.
In various embodiments, a plurality of itaconate molecules (e.g., an itaconate as described and claimed herein) are comprised in a solution. In various embodiments, the solution is an aqueous solution. In various embodiments, the solution further comprises an alcohol cosolvent. An alcohol cosolvent can be ethanol or isopropyl alcohol. In some embodiments, an alcohol can be added to alter and/or control the rate of evaporation (e.g., when used as a disinfectant or coating). An alcohol cosolvent can also enhance antimicrobial activity of the composition due to the antimicrobial effect of the alcohol itself. In various embodiments, the composition can include an additional antimicrobial agent. In various embodiments, the solution does not comprise another polymer (e.g., to alter and/or improve coating properties). In various embodiments, the solution further comprises free Ag and/or Cu ions complexed with itaconic acid moieties.
In various embodiments, the itacontaes can be added to other existing products like paints, hand sanitizers, soaps, food wax, and the like, to impart or enhance antimicrobial properties of the products. In various embodiments, the itacontaes can be formulated with an alcohol (e.g., isopropyl alcohol, ethanol) and can be added to hand sanitizer formulation to further enhance broad spectrum efficacy.
In various embodiments, the itaconates can be used as anti scaling agents.
Without wishing to be bound by any particular theory, it is believed that the itaconates can act as antiscaling agents based on affinity of itaconic acid to Mg/Ca ions.
Alternatively, in various embodiments, the solution does not comprise another metal and/or antimicrobial agent in addition to the itaconate.
Methods of Making Itaconates and Poly Itaconates
In various aspects, the invention also provides a method for making an itaconate (e.g., formula I, or as otherwise disclosed herein), comprising: (1) electrolyzing of silver (Ag) or copper (Cu) in an itaconic acid (C5H6O4) solution, thereby producing silver or copper itaconate (C5H5AgO4 or C5H5CuO4) and/or disilver or dicopper itaconate (C5H4Ag2O4 or C5H5Cu2O4), and (2) polymerizing the itaconate produced in (1). Such synthetic schemes are discussed in detail in Example 1 below, as illustrated in connection with
In various embodiments, the method of making the itaconate is conducted as a one pot synthesis. A one pot synthesis can provide practical advantages including reducing synthesis time and/or cost. For example, the one pot synthesis can help avoiding separation and purification of intermediate chemical compounds, and can otherwise time and resources while increasing chemical yield.
In various embodiments, the method of making the itaconate is conducted as an aqueous polymerization or an emulsion polymerization. In various embodiments, aqueous polymerization is the cheapest method and has the added advantage of not requiring solvent recovery. However, in other embodiments, emulsion polymerization can result in higher molecular weight polymer and lower polydispersity.
Variations and alternatives will be understood by those skilled in the art and in view of the instant disclosure. For example, alternative synthetic methodologies can include electrolytic introduction of the metal (e.g., Ag and/or Cu) ions.
Antimicrobial Uses, Coatings, Articles
In various aspects, the invention can be used as an antimicrobial agent, for example as a disinfectant (e.g., the itaconate in solution, applied as a wash, spray, aerosol, or the like). Although application of the itaconate solution can result in an antimicrobial coating (discussed below), embodiments of the invention specifically contemplate the use of the itaconates as antimicrobial agents independent of any coating properties.
In various aspects, the invention also includes a method of providing an antimicrobial surface comprising coating an article with an itaconate. For example, the itaconate can be supplied as a solution (e.g., in a solvent) and dipped or sprayed onto the surface of the article (e.g., as an aerosol). As the solvent evaporates (e.g., by air drying or in an oven) the process can leave a film of polymer/metal ions on the surface of the article. One skilled in the art can adapt known disinfection and coating methodologies to the instant invention.
Furthermore, in various aspects, the invention provides an article having an antimicrobial coating comprising an itaconate. For example, the article can be a medical item, consumer goods, industrial equipment, or another thing that can be improved by incorporation of an antimicrobial treatment or coating.
The invention has many application in the medical field (e.g., disinfecting and/or coating hospital and surgical equipment, wound dressings, and the like), in food service (e.g., preparation surface disinfection and equipment disinfection, water supply, and the like), in preventing biofilm formation (e.g., in pipelines, keeping flowing waterlines free of microbial contamination, cooling tower lines, underground drilling lines, chemical and nuclear plants, and the like), in agriculture and horticulture (e.g., disinfectant spray formulation for green houses or aerial spraying), as a general additive to plastics or other materials, to impart antimicrobial properties, in personal care products (e.g., diapers, band aids, sanitary pads, disinfecting wipes, and the like), in warehouse, storage, commercial vehicle, and building disinfection, as a general treatment to yarns or fibers (e.g., to make antimicrobial clothing, woven materials, bandages, wound dressings, and the like), and in electrospinning the polymer in native or blended for to create antimicrobial mats. Furthermore, materials according to the invention can be used as plastic additives, to impart antimicrobial properties in plastics.
As already discussed, in various embodiments, the invention has numerous application in hospitals, the food and beverage industry, in pharmaceutical, and in manufacturing. In one embodiment, a coating according to the invention is formulated or used for, an aqueous and/or alcohol based spray for hard surface disinfection. In one embodiment, a coating according to the invention is formulated, or used, for and aqueous and/or alcohol based aerosol for operation theater, manufacturing plant, or warehouse disinfection. In one embodiment, a coating according to the invention is formulated, or used, for sanitizing tanks, pipelines, or other food & beverage or pharmaceutical manufacturing equipment internals. In one embodiment, a coating according to the invention is formulated, or used, for spraying fruits and vegetables to mitigate infection. In one embodiment, a coating according to the invention is formulated, or used, as an additive to wax used to coat fruits & vegetables (e.g., apples) to extend shelf life. In one embodiment, a coating according to the invention is formulated, or used, for coating crates and packaging material.
As already discussed, in various embodiments, the invention has numerous application in agriculture, horticulture, poultry and dairy. In one embodiment, a coating according to the invention is formulated or used in spray or aerosolized form in green houses and aerial spraying for farm lands. In one embodiment, a coating according to the invention is formulated or used for soil preparation for green houses. In one embodiment, a coating according to the invention is formulated or used for sanitization of poultry and dairy farms in aerosol and/or spray form. In one embodiment, a coating according to the invention is formulated or used for disinfecting dairy animal (e.g., cow) udders in lotion or spray form.
This example describes synthetic schemes for preparing silver and/or copper itaconate by electrolysis of silver or copper in an itaconic acid solution. This example further describes a method for polymerizing the silver and/or copper itaconate into poly itaconates.
The synthetic scheme shown in
Similar to
Similarly,
Variations on these synthetic schemes, as well as suitable alternatives, will be understood to those skilled in the art in view of the instant disclosure. Illustrative examples showing implementations of these synthetic schemes are discussed in Examples 2-4 below.
This example describes the preparation of different silver itaconate solutions.
To prepare the positive control solution (Sample I), three solutions were prepared and labeled A, B, or C. Solution A contained 0.145 M phosphoric acid. Solution B contained 0.85 M nitric acid and 1.47 M silver nitrate. Solution C contained 4.7 M of tartaric acid. To prepare the stock solution, 16.2 mL of Solution A, 22.7 mL of Solution 13, and 6.8 mL of Solution C was mixed together and the volume was made up to 40 mL. This stock was diluted in 30% hydrogen peroxide and water to form the final solution as shown in Table 1.
A stock of silver itaconate was prepared by electrolysis of a silver electrode in 0.25 M itaconic acid solution using a DC source set at 23.9 V for 30 minutes at ambient temperature. The concentration of silver obtained by this process was 262 ppm. Next, this stock silver itaconate was blended with 30% (w/w) hydrogen peroxide in two dilution ratios to result in silver itaconate Samples IV and V as shown in Table 2.
A stock solution of silver stabilized in itaconic acid was prepared by first dissolving 6.8 g of itaconic acid in 200 mL of reverse osmosis/deionized water (RO/DI). Next, 5.6 g of silver nitrate was added to this solution. The salts were mixed at ambient temperature until fully dissolved. Finally, this stock solution of silver stabilized in itaconic acid was blended with 30% (w/w) hydrogen peroxide or RO/DI in dilution ratios to result in Samples II and III as shown in Table 3.
This example describes the antimicrobial activity of the silver itaconate solutions from Example 2. Specifically, the Samples I-V from Example 2 were tested for efficacy against Staphylococcus aureus (ATCC#6538) and Pseudomonas aeruginosa (ATCC#15442) using the standard practices based on Association of Analytical Chemists (AOAC) disinfection test protocol dilution method for hard surfaces. For current work, a truncated study was performed with 20 carriers versus 60 recommended in the standard method. Efficacy of the disinfectant samples was tested at 25° C. for a contact time of ten minutes. Killing of the test organism on a total of 20 carriers was monitored. The results are summarized in Table 4, which shows that all five silver itaconate solutions (Samples I-V) effectively killed the test organisms and would be useful as antimicrobial agents.
Pseudomonas
aeruginosa
Staphylococcus
aureus
This example describes the preparation any physical characterization of different itaconate solutions.
Sample VI:
A control solution (Sample VI) for aqueous itaconic acid polymerization (sodium poly itaconate) was prepared using the following procedure: First, 240 of RO/DI was heated to 85° C. and 230 g of itaconic acid was added. After the itaconic acid was completely dissolved, 142 g of 50% NaOH was gradually added over 1 hr. The reaction was allowed to continue for an additional 1 hr. Next, 75 mL of 30% hydrogen peroxide was gradually added over 1 hr. The reactants continued to mix at 85° C. for an additional 3 hrs and 20 minutes. The aqueous polymer obtained had an appearance of viscous yellow gel. Molecular weight for the control sample was analyzed by MALDI-TOF spectra as shown in
All samples were deposited on the MALDI target plates by drop casting and annealing in vacuum over at 30° C. MALDI-TOF MS data were acquired using a WATERS Micromass spectrometer. The instrument is equipped with a 337 nm pulsed nitrogen laser. TOF data from 20-50 individual laser pulses exposure were recorded and averaged on a transient digitizer, after which averaged spectra were automatically converted into mass by MassLynx data processing software.
Sample VII:
A solution of silver poly itaconate (Sample VII) was prepared using the following procedure: First, 240 mL of RO/DI was heated to 85° C. and 230 g of itaconic acid was added. After the itaconic acid was completely dissolved, electrolysis of silver electrode in this solution using a DC source set at 23.9 V was initiated. Electrolysis was carried out for 60 minutes at 85° C. After electrolysis was completed, 75 mL of 30% hydrogen peroxide was added over 1 hr in 3 bolus additions of 25 mL each. Post addition, the reaction was continued for an additional 1 hr at 85° C. The aqueous polymer obtained had an appearance of viscous colorless gel. The silver concentration in the final sample was 2840 mg/L based on atomic absorption spectroscopy. Molecular weight for the silver poly itaconate sample was analyzed by MALDI-TOF spectra as shown in
Sample VIII:
A solution of copper poly itaconate (Sample VIII) was prepared using the following procedure: First, 240 mL of RO/DI was heated to 85° C. and 230 g of itaconic acid was added. After the itaconic acid was completely dissolved, electrolysis of copper electrode in this solution using a DC source set at 23.9 V was initiated. Electrolysis was carried out for 60 minutes at 85° C. After electrolysis was completed, 50 mL of 30% hydrogen peroxide was added over 40 min in 2 bolus additions of 25 mL each. Post addition, the reaction was continued for an additional 1 hr at 85° C. The aqueous polymer obtained had an appearance of viscous green gel. The copper concentration in the final sample was 1622 mg/L based on atomic absorption spectroscopy. Molecular weight for the copper poly itaconate sample was analyzed by MALDI-TOF spectra as shown in
Sample IX:
Finally, a solution of poly itaconate using silver oxide (silver oxide solution, Sample IX) was prepared using the following procedure: First, 240 mL of RO/DI was heated to 85° C. and 230 g of itaconic acid was added. After the itaconic acid was completely dissolved, 0.503 g of silver oxide was added. After the silver oxide was well dispersed, 75 mL of 30% hydrogen peroxide was added over 1 hr in 3 bolus additions of 25 mL each. Post addition, the reaction continued for an additional 1 hr at 85° C. The aqueous polymer obtained had an appearance of viscous colorless gel. The silver concentration in the final sample was 1520 mg/L based on atomic absorption spectroscopy. Molecular weight for the silver oxide sample was analyzed by MALDI-TOF Spectra as shown in
This example describes the antimicrobial activity of the silver itaconate solutions from Example 4. Specifically, Samples VI-IX (sodium poly itaconate, silver poly itaconate, copper poly itaconate, and poly itaconate using silver oxide) were tested for Minimal inhibitory Concentration (MIC) against Pseudomonas aeruginosa (ATCC #9027) and Methicillin-resistant Staphylococcus aureus (ATCC#43300) using the standard CLSI/NCCLS method. MIC is defined as the lowest concentration of an antimicrobial compound that still prevents growth of the organism it is tested against. The MIC results are shown in Table 5.
P. aeruginosa and S. aureus
P. aeruginosa
S. aureus
As shown in Table 5, sodium poly itaconate (control) had no measured efficacy against the test organisms whereas the 20× diluted silver and copper poly itaconate solutions had. MIC values of 6.25% against Pseudomonas aeruginosa and Methicillin-resistant Staphylococcus aureus. Furthermore, the 20× diluted silver oxide solution had. MIC values of 6.25% and 3.125% against Pseudomonas aeruginosa and Methicillin-resistant Staphylococcus aureus, respectively. Thus, these example silver and copper itaconate solutions (Samples VII-IX) effectively killed the test organisms and would be useful as antimicrobial agents.
The specification is most thoroughly understood in light of the teachings of the references cited within the specification. The embodiments within the specification provide an illustration of embodiments of the invention and should not be construed to limit the scope of the invention. The skilled artisan readily recognizes that many other embodiments are encompassed by the invention. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
This Application is a National Stage Application of the International Patent Application PCT/US2016/047277 filed on Aug. 17, 2016. Application PCT/US2016/047277 claims the benefit of U.S. Provisional Application 62/208,009 filed on Aug. 21, 2015. The entire contents of these applications are incorporated herein by reference in their entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2016/047277 | 8/17/2016 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2017/034871 | 3/2/2017 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 2294226 | D'Alello | Aug 1942 | A |
| 3055873 | Hull et al. | Sep 1962 | A |
| 3560529 | Blumbergs et al. | Feb 1971 | A |
| 3702298 | Zsoldos, Jr. et al. | Nov 1972 | A |
| 3984341 | Haschke et al. | Oct 1976 | A |
| 4016124 | Crisp et al. | Apr 1977 | A |
| 4072784 | Cirino et al. | Feb 1978 | A |
| 4666616 | Rossmoore | May 1987 | A |
| 4882277 | Czytko et al. | Nov 1989 | A |
| 4915955 | Gomori | Apr 1990 | A |
| 4917836 | Yamane et al. | Apr 1990 | A |
| 5008106 | Merianos et al. | Apr 1991 | A |
| 5073382 | Antelman | Dec 1991 | A |
| 5078902 | Antelman | Jan 1992 | A |
| 5182169 | Fukuda et al. | Jan 1993 | A |
| 5223590 | Hughes et al. | Jun 1993 | A |
| 5223592 | Hughes et al. | Jun 1993 | A |
| 5225392 | Chang et al. | Jul 1993 | A |
| 5326966 | Fukuda et al. | Jul 1994 | A |
| 5332559 | Brierley et al. | Jul 1994 | A |
| 5336744 | Swift et al. | Aug 1994 | A |
| 5437858 | Hungerbach et al. | Aug 1995 | A |
| 5464559 | Marchin et al. | Nov 1995 | A |
| 5656646 | Pemer et al. | Aug 1997 | A |
| 5731361 | Horn et al. | Mar 1998 | A |
| 5744292 | Yoneyama | Apr 1998 | A |
| 5834294 | Brierley et al. | Nov 1998 | A |
| 5889088 | Kisuno et al. | Mar 1999 | A |
| 5916487 | Weidlich et al. | Jun 1999 | A |
| 5945032 | Breitenbach et al. | Aug 1999 | A |
| 6130304 | Sumiya et al. | Oct 2000 | A |
| 6162391 | Kowata et al. | Dec 2000 | A |
| 6197814 | Arata | Mar 2001 | B1 |
| 6280748 | Morita et al. | Aug 2001 | B1 |
| 6303711 | Sumiya et al. | Oct 2001 | B1 |
| 6306460 | Reck et al. | Oct 2001 | B1 |
| 6503691 | Goodin et al. | Jan 2003 | B1 |
| 6838095 | Newman et al. | Jan 2005 | B2 |
| 6893810 | Sakai et al. | May 2005 | B1 |
| 7491777 | Jakob et al. | Feb 2009 | B2 |
| 7732486 | Arata | Jun 2010 | B2 |
| 7951404 | Gomori | May 2011 | B2 |
| 8399003 | Krall et al. | Mar 2013 | B2 |
| 9757387 | Karandikar | Sep 2017 | B2 |
| 20020007005 | Reck et al. | Jan 2002 | A1 |
| 20020009596 | Mizutani | Jan 2002 | A1 |
| 20030060537 | Palazzo | Mar 2003 | A1 |
| 20030064328 | Friedel | Apr 2003 | A1 |
| 20030065058 | Piedrahita et al. | Apr 2003 | A1 |
| 20030065090 | Kelly et al. | Apr 2003 | A1 |
| 20030078338 | Schlarb et al. | Apr 2003 | A1 |
| 20030132166 | Rey | Jul 2003 | A1 |
| 20030162129 | Goodin et al. | Aug 2003 | A1 |
| 20030164105 | Tashiro | Sep 2003 | A1 |
| 20030230967 | Kawamura et al. | Dec 2003 | A1 |
| 20040001947 | Kawamura et al. | Jan 2004 | A1 |
| 20040067434 | Kano et al. | Apr 2004 | A1 |
| 20040081911 | Noglik et al. | Apr 2004 | A1 |
| 20040096421 | Kurihara et al. | May 2004 | A1 |
| 20040156912 | Kawamura et al. | Aug 2004 | A1 |
| 20040168820 | Kanamori et al. | Sep 2004 | A1 |
| 20040185238 | Kawamura et al. | Sep 2004 | A1 |
| 20050106348 | Koike et al. | May 2005 | A1 |
| 20060052503 | Shimizu et al. | Mar 2006 | A1 |
| 20060153903 | Leno et al. | Jul 2006 | A1 |
| 20060198802 | Ito et al. | Sep 2006 | A1 |
| 20070232489 | Tatewaki et al. | Oct 2007 | A1 |
| 20080003424 | Kawamura | Jan 2008 | A1 |
| 20080004175 | Aoshima et al. | Jan 2008 | A1 |
| 20080027180 | Higashimoto et al. | Jan 2008 | A1 |
| 20080071024 | Morishita et al. | Mar 2008 | A1 |
| 20080113892 | Barnhart et al. | May 2008 | A1 |
| 20080193405 | Mukherjee et al. | Aug 2008 | A1 |
| 20080194434 | Huff et al. | Aug 2008 | A1 |
| 20090114108 | Oya et al. | May 2009 | A1 |
| 20100009010 | Gomori | Jan 2010 | A1 |
| 20100189599 | Bobbert | Jul 2010 | A1 |
| 20100247911 | Aso et al. | Sep 2010 | A1 |
| 20100255321 | Jahns et al. | Oct 2010 | A1 |
| 20110042302 | Shooshtari et al. | Feb 2011 | A1 |
| 20110091733 | Feuerhake et al. | Apr 2011 | A1 |
| 20110171151 | Arnaud et al. | Jul 2011 | A1 |
| 20110224393 | Durant et al. | Sep 2011 | A1 |
| 20110244256 | Song et al. | Oct 2011 | A1 |
| 20120010338 | Terrenoire et al. | Jan 2012 | A1 |
| 20120098160 | Watanabe et al. | Apr 2012 | A1 |
| 20120196972 | Balk et al. | Aug 2012 | A1 |
| 20120208958 | Jahns et al. | Aug 2012 | A1 |
| 20130101494 | Ural et al. | Apr 2013 | A1 |
| 20130118531 | Dobrawa et al. | May 2013 | A1 |
| 20130123160 | Dobrawa et al. | May 2013 | A1 |
| 20130123372 | Dobrawa et al. | May 2013 | A1 |
| 20130133548 | Shooshtari et al. | May 2013 | A1 |
| 20130197123 | Kaneko | Aug 2013 | A1 |
| 20130338227 | Saint Victor et al. | Dec 2013 | A1 |
| 20130338281 | Aso | Dec 2013 | A1 |
| 20140107273 | Ochiai et al. | Apr 2014 | A1 |
| 20140127274 | Arnaud et al. | May 2014 | A1 |
| 20140134094 | Aso et al. | May 2014 | A1 |
| 20140147410 | Ghosh et al. | May 2014 | A1 |
| 20140213692 | Zhang et al. | Jul 2014 | A1 |
| 20140296352 | Arnaud | Oct 2014 | A1 |
| Number | Date | Country |
|---|---|---|
| 101293823 | Oct 2011 | CN |
| 1 281 787 | Feb 2003 | EP |
| 1 108 534 | Aug 2005 | EP |
| 2 230 312 | Sep 2010 | EP |
| 2 493 574 | Jun 2014 | EP |
| 2968219 | Jun 2012 | FR |
| 2005331725 | Dec 2005 | JP |
| 2008-238020 | Oct 2008 | JP |
| 2008-239764 | Oct 2008 | JP |
| 9601231 | Jan 1996 | WO |
| 0151009 | Jul 2001 | WO |
| 0177238 | Oct 2001 | WO |
| 2008117778 | Oct 2008 | WO |
| 2008117780 | Oct 2008 | WO |
| 2009015286 | Jan 2009 | WO |
| 2009044146 | Apr 2009 | WO |
| 2009076491 | Jun 2009 | WO |
| 2010026534 | Mar 2010 | WO |
| 2010105851 | Sep 2010 | WO |
| 2011051323 | May 2011 | WO |
| 2011051374 | May 2011 | WO |
| 2011089085 | Jul 2011 | WO |
| 2012073080 | Jun 2012 | WO |
| 2012076426 | Jun 2012 | WO |
| 2012109130 | Aug 2012 | WO |
| 2012144233 | Oct 2012 | WO |
| 2013001172 | Jan 2013 | WO |
| 2013068272 | May 2013 | WO |
| 2013068384 | May 2013 | WO |
| 2013068479 | May 2013 | WO |
| 2013083247 | Jun 2013 | WO |
| 2013188508 | Dec 2013 | WO |
| 2014057993 | Apr 2014 | WO |
| 2014083175 | Jun 2014 | WO |
| 2014143773 | Sep 2014 | WO |
| 2014179353 | Nov 2014 | WO |
| 2015096055 | Jul 2015 | WO |
| 2015100412 | Jul 2015 | WO |
| Entry |
|---|
| Lehtonen, P.O. Finnish Chemical Letters, 1986, 13(5), 141-149. (Year: 1986). |
| Tomić, S.Lj.; Filipović, J.M.; Vrhovac, Lj.P.; Playsić, M.B. Physical Chemistry 2000, Proceedings of the International Conference on Fundamental and Applied Aspects of Physical Chemistry, 5th, Belgrade, Yugoslavia; Sep. 27-29, 2000 (2000), 498-500. ( Year: 2000). |
| Bal, A et al., “Synthesis and Characterization of Copolymeric and Terpolymeric Hydrogel-Silver Nanocomposites Based on Acrylic Acid, Acrylamide and Itaconic Acid: Investigation of Their Antibacterial Activity Against Gram-Negative Bacteria,” Brazilian Journal of Chemical Engineering, vol. 32, No. 2, pp. 509-518, Apr.-Jun. 2015; abstract; p. 510, col. 2, paragraphs 3, 5; p. 511, col. 1, paragraphs 1-3, p. 511, col. 2, Table 2 (10 pages). |
| Gupta, P et al., “Investigation of Antibacterial Properties of Silver Nanoparticle-loaded Poly (acrylamide-co-itaconic acid)- Grafted Cotton Fabric,” The Journal of Cotton Science, vol. 12, pp. 280-286, 2008; abstract; p. 282, col. 1, paragraphs 3-6; col. 2, paragraphs 1-4 (7 pages). |
| International Search Report and Written Opinion for International Application No. PCT/US2016/047277 dated Oct. 18, 2016 (9 pages). |
| Eid, M., et al., Bactericidal effect of poly(acrylamide/itaconic acid)-silver nanoparticles synthesized by gamma irradiation against Pseudomonas aeruginosa. Appl Biochem Biotechnol. Sep. 2013;171(2):469-87. DOI: 10.1007/s12010-013-0357-1. Epub Jul. 16, 2013. |
| Extended European Search Report for Application No. EP16839830.3 dated Feb. 21, 2019 (8 pages). |
| Guadalupe Rodriguez-Delgado, M., et al., Preparation and characterization of acrylic acid/itaconic acid hydrogel coatings containing silver nanoparticles. Journal of Applied Polymer Science. Nov. 15, 2013;130 (4):2713-2721. |
| Jova{hacek over (s)}ević, J.S., et al., [Antimikrobna aktivnost hibridnih hidrogelova na bazi poli(vinilpirolidona) koji sadr{hacek over (z)}e srebro] Antimicrobial activity of hybrid hydrogels based on poly(vinylpyrrolidone) containing silver. Hemijska Industrija. 2010;64(3):209-214. Serbian-language article, with English abstract on p. 214. |
| Jova{hacek over (s)}ević, J.S., et al., Swelling, Mechanical and Antimicrobial Studies of Ag/P (HEMA/IA)/PVP Semi-IPN Hybrid Hydrogels. Acta Physica Polonica A. Aug. 2011;120(2):279-283. |
| Ka{hacek over (c)}arević-Popović, Z., et al., On the Use of Radiation Technology for Nanoscale Engineering of Silver/Hydrogel Based Nanocomposites for Potential Biomedical Application. The Open Conference Proceedings Journal. 2010;1:200-206. |
| Kansoh, A.L., et al., Evaluation of the antifungal activities of the novel synthesized chelating co-polymer emulsion attices and their silver complexes. Egyptian Journal of Biotechnology. 2004;17:60-73. |
| Kansoh, A.L., et al., Studies on the antifungal activities of the novel synthesized chelating co-polymer emulsion attices and their silver complexes. Biotechnol Agron Soc Environ. 2008;12(3):231-238. |
| Kochkin, D. A., et al., Organotin citraconates and itaconates. Zhumal Obshchei Khimii. 1973;43(12):2709-12. Russian-language article. |
| Michelucci, A., et al., Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A. May 7, 2013;110(19):7820-5. doi: 10.1073/pnas.1218599110. Epub Apr. 22, 2013. |
| Mićić, M.M, et al., [Kompleksi srebra I kopolimernih hidrogelova na bazi itakonske kiseline] Silver(I)-complexes with an itaconic acid-based hydrogel. Hemijska Industrija. Nov. 3, 2009;63(3)137-142. Serbian-language article, with English abstract on p. 142. |
| Mićić, M.M., et al., Radiation synthesis, characterization and antimicrobial application of novel copolymeric silver/poly (2-hydroxyethyl methacrylate/itaconic acid) nanocomposite hydrogels. Polymer Bulletin (Heidelberg, Germany). Dec. 2013;70(12):3347-3357. |
| Qu, S., et al., Metal ion mediated molecularly imprinted polymer for selective capturing antibiotics containing beta-liketone structure. J Chromatogr A. Dec. 24, 2010;1217(52):8205-11. doi: 10.1016/j.chroma.2010.10.097. Epub Oct. 30, 2010. |
| Rodriguez-Delgado, M.G., et al., Preparation and characterization of acrylic acid/itaconic acid hydrogel coatings containing silver nanoparticles. Journal of Applied Polymer Science. Nov. 15, 2013;130(4):2713-2721. |
| Rowland, S.P., et al., Enhanced DP Finishing of Cotton with Dimethyloldihydroxyethyleneurea and a Metal Acrylate-Type Monomer. Textile Research Journal. Nov. 1, 1978;48(11):625-632. |
| Sánchez-Valdez, S., et al., Silver nanoparticle deposition on hydrophilic multilayer film surface and its effect on antimicrobial activity. Journal of Applied Polymer Science. Mar. 5, 2012;123(5):2643-2650. |
| Tomić, S.LJ., et al., Preparation of Silver(I) Complexes with Itaconic Acid-Based Hydrogels for Biomedical Application. Materials and Manufacturing Processes. Sep. 2009;24(10 & 11):1197-1201. |
| Weng, Y., et al., A PQAS-containing glass-ionomer cement for improved antibacterial function. Journal of Biomedial Science and Engineering. 2010;3(10):955-962. |
| Number | Date | Country | |
|---|---|---|---|
| 20180251578 A1 | Sep 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62208009 | Aug 2015 | US |
